IL172840A0 - Benzimidazole derivatives and their use as protein kinases inhibitors - Google Patents
Benzimidazole derivatives and their use as protein kinases inhibitorsInfo
- Publication number
- IL172840A0 IL172840A0 IL172840A IL17284005A IL172840A0 IL 172840 A0 IL172840 A0 IL 172840A0 IL 172840 A IL172840 A IL 172840A IL 17284005 A IL17284005 A IL 17284005A IL 172840 A0 IL172840 A0 IL 172840A0
- Authority
- IL
- Israel
- Prior art keywords
- protein kinases
- benzimidazole derivatives
- kinases inhibitors
- inhibitors
- benzimidazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48468503P | 2003-07-03 | 2003-07-03 | |
GBGB0315657.7A GB0315657D0 (en) | 2003-07-03 | 2003-07-03 | Pharmaceutical compounds |
US51437403P | 2003-10-24 | 2003-10-24 | |
GB0324919A GB0324919D0 (en) | 2003-10-24 | 2003-10-24 | Pharmaceutical compounds |
PCT/GB2004/002824 WO2005002552A2 (en) | 2003-07-03 | 2004-07-05 | Benzimidazole derivatives and their use as protein kinases inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
IL172840A0 true IL172840A0 (en) | 2006-06-11 |
IL172840A IL172840A (en) | 2014-07-31 |
Family
ID=33568694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL172840A IL172840A (en) | 2003-07-03 | 2005-12-27 | Benzimidazole derivatives and their use as protein kinase inhibitors |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR101190964B1 (en) |
CY (2) | CY1114846T1 (en) |
HK (1) | HK1087925A1 (en) |
IL (1) | IL172840A (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA04003954A (en) * | 2001-10-26 | 2004-11-29 | Aventis Pharma Inc | Benzimidazoles and analogues and their use as protein kinases inhibitors. |
-
2004
- 2004-07-05 KR KR1020067000119A patent/KR101190964B1/en not_active IP Right Cessation
-
2005
- 2005-12-27 IL IL172840A patent/IL172840A/en not_active IP Right Cessation
-
2006
- 2006-07-24 HK HK06108214.7A patent/HK1087925A1/en not_active IP Right Cessation
-
2014
- 2014-01-28 CY CY20141100070T patent/CY1114846T1/en unknown
- 2014-04-28 CY CY20141100311T patent/CY1115093T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20060082847A (en) | 2006-07-19 |
IL172840A (en) | 2014-07-31 |
KR101190964B1 (en) | 2012-10-12 |
HK1087925A1 (en) | 2006-10-27 |
CY1115093T1 (en) | 2016-12-14 |
CY1114846T1 (en) | 2016-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1648426T1 (en) | Benzimidazole derivatives and their use as protein kinases inhibitors | |
IL176233A0 (en) | Organophosphorous indazole derivatives and use thereof as protein kinase inhibitors | |
IL161576A0 (en) | Benzimidazoles and analogues and their use as protein kinases inhibitors | |
ZA200500680B (en) | Quinoline derivatives and their use as mycrobacterial inhibitors | |
IL173380A0 (en) | Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors | |
ZA200704888B (en) | Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases | |
PL376789A1 (en) | Aminoindazole derivatives and use thereof as kinase inhibitors | |
IL173490A0 (en) | 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors | |
PT1562589E (en) | Diaminotriazoles useful as inhibitors of protein kinases | |
PL375447A1 (en) | Protein kinase inhibitors and uses thereof | |
PL403456A1 (en) | 5-phenylthiazole derivatives and their use as Pi3 kinase inhibitors | |
IL161516A0 (en) | Benzimidazoles useful as protein kinase inhibitors | |
IL151045A0 (en) | 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors | |
HK1099764A1 (en) | Quinoxalines useful as inhibitors of protein kinases | |
PT1997811E (en) | Indazole, benzoxazole and pyrazolopyridine derivatives as p38 kinase inhibitors | |
HK1112895A1 (en) | 5-heteroaryl thiazoles and their use as pi3k inhibitors | |
HK1067945A1 (en) | Substituted benzazoles and use thereof as raf kinase inhibitors | |
AU2003256297A1 (en) | Benzimidazoles and benzothiazoles as inhibitors of map kinase | |
AU2003254053A8 (en) | Pyrazolopyrimidines as protein kinase inhibitors | |
IL172257A0 (en) | Substituted pyrrole derivatives and their use as hmg-co inhibitors | |
ZA200606070B (en) | Substituted quinolines and their use as mycrobacterial inhibitors | |
EP1922086A4 (en) | Targeted protein kinase c inhibitors and uses thereof | |
EP1877424A4 (en) | Inhibitors of protein kinases and uses thereof | |
AU2003215756A8 (en) | Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors | |
PL374581A1 (en) | Diaminothiazoles and use thereof as cdk4 inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |